EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Share-based Compensation (2010 - 2026)

EyePoint (EYPT) posted Share-based Compensation of $58.3 million for Q1 2026, up 2464.89% sequentially from $2.3 million in Q4 2025, and up 6356.26% YoY from $903000.0 in Q1 2025.

Analysis

EyePoint (EYPT) Share-based Compensation (2010 - 2026) Analysis & Trends

EyePoint has reported Share-based Compensation for 17 years, with the latest figure at $58.3 million in Q1 2026.

  • Quarterly Share-based Compensation rose 6356.26% year-over-year to $58.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.3 million (up 260.52% YoY) and the FY2025 annual result came in at $21.3 million, down 42.03% from the prior year.
  • Share-based Compensation grew to $58.3 million in Q1 2026 per EYPT's latest filing, from $2.3 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $58.3 million in Q1 2026 and troughed at -$8.5 million in Q4 2023.
  • A 5-year average of $6.2 million and a median of $3.2 million in 2022 frame the typical range for Share-based Compensation.
  • The sharpest annual moves came in 2022 and 2023: Share-based Compensation jumped 67120.0% in 2022, then slumped 351.92% in 2023.
  • Over 5 years, Share-based Compensation stood at $3.4 million in 2022, then plunged by 351.92% to -$8.5 million in 2023, then soared by 193.3% to $7.9 million in 2024, then sank by 71.23% to $2.3 million in 2025, then soared by 2464.89% to $58.3 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $58.3 million, $2.3 million, and -$132000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00 50.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.40 Mn
Mar 31, 2026 58.30 Mn
Dec 31, 2025 6.75 Mn
Sep 30, 2025 9.44 Mn
Jun 30, 2025 9.48 Mn
Mar 31, 2025 9.39 Mn
Dec 31, 2024 7.90 Mn
Sep 30, 2024 7.70 Mn
Jun 30, 2024 8.70 Mn
Mar 31, 2024 12.70 Mn
Dec 31, 2023 3.59 Mn
Sep 30, 2023 6.34 Mn
Jun 30, 2023 6.17 Mn
Mar 31, 2023 6.07 Mn
Dec 31, 2022 3.36 Mn
Sep 30, 2022 4.03 Mn
Jun 30, 2022 4.14 Mn
Mar 31, 2022 3.97 Mn
Dec 31, 2021 2.81 Mn
Sep 30, 2021 2.47 Mn